In silico oncology: Part I—clinically oriented cancer multilevel modeling based on discrete event simulation

Multiscale Cancer Modeling

Volumn , Issue , 2010, Pages 407-431

  Stamatakos, Georgios S ^a  

^a NATIONAL TECHNICAL UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85012138656     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b10407     Document Type: Chapter

References (58)

1. Antipas, V., G.S. Stamatakos, N. Uzunoglu, D. Dionysiou, and R. Dale. 2004. A spatiotemporal simulation model of the response of solid tumors to radiotherapy in vivo: parametric validation concerning oxygen enhancement ratio and cell cycle duration. Phys Med Biol 49: 1-20.
2. Antipas, V.P., G.S. Stamatakos, and N.K. Uzunoglu. 2007. A patient-specific in vivo tumor and normal tissue model for prediction of the response to radiotherapy: a computer simulation approach. Meth Inf Med 46: 367-375.
3. Bobola, M.S., S. H. Tseng, A. Blank, M.S. Berger, and J.R. Silber. 1996. Role of O6-methylguanine-DNA methyltransferase in resistance of human brain tumor cell lines to the clinically relevant methylating agents temozolomide and streptozotocin. Clin Cancer Res 2: 735-741.
4. Breward, C.J., Byrne H.M., and C.E. Lewis. 2003. A multiphase model describing vascular tumour growth. Bull Math Biol 65(4): 609-640.
5. Clatz, O., Sermesant M., Bondiau P.Y., Delingette H., Warfield S.K., Malandain G., and Ayache N. 2005. Realistic simulation of the 3-D growth of brain tumors in MR images coupling diffusion with biomechanical deformation. IEEE Trans Med Imaging 24(10): 1334-1346.
6. Cristini, V., H.B. Frieboes, R. Gatenby, S. Caserta, M. Ferrari, and J.P. Sinek. 2005. Morphological instability and cancer invasion. Clin Cancer Res 11: 6772-6779.
7. Dionysiou, D.D., G.S. Stamatakos, N.K. Uzunoglu, K.S. Nikita, and A. Marioli, 2004. A four-dimensional simulation model of tumour response to radiotherapy in vivo: parametric validation considering radiosensitivity, genetic profile and fractionation. J Theor Biol 230: 1-20.
8. Dionysiou, D.D. and G.S. Stamatakos. 2006. Applying a 4D multiscale in vivo tumor growth model to the exploration of radiotherapy scheduling: the effects of weekend treatment gaps and p53 gene status on the response of fast growing solid tumors. Cancer Informatics 2: 113-121.
9. Dionysiou, D.D., G.S. Stamatakos, N.K. Uzunoglu, and K.S. Nikita. 2006a. A computer simulation of in vivo tumour growth and response to radiotherapy: new algorithms and parametric results. Comput Biol Med 36: 448-464.
10. Dionysiou, D.D., G.S. Stamatakos, N.K. Uzunoglu, and K.S. Nikita. 2006b. A computer simulation of in vivo tumour growth and response to radiotherapy: new algorithms and parametric results. Comput Biol Med 36: 448-464.
11. Dionysiou, D.D., G.S. Stamatakos, and K. Marias. 2007. Simulating cancer radiotherapy on a multi-level basis: biology, oncology and image processing. Lect Notes Comput Sci 4561: 569-575.
12. Dionysiou, D.D., G.S. Stamatakos, D. Gintides, N. Uzunoglu, and K. Kyriaki. 2008. Critical parameters determining standard radiotherapy treatment outcome for glioblastoma multiforme: a computer simulation. Open Biomed Eng J 2: 43-51.
13. D’Onofrio, A. 2005. A general framework for modeling tumor-immune system competition and immunotherapy: analysis and medical inferences. Physica D 208: 220-235.
14. Duechting, W. and T. Vogelsaenger. 1981. Three-dimensional pattern generation applied to spheroidal tumor growth in a nutrient medium. Int J Biomed Comput 12 (5): 377-392.
15. Duechting, W., W. Ulmer, R. Lehrig, T. Ginsberg, and E. Dedeleit. 1992. Computer simulation and modeling of tumor spheroid growth and their relevance for optimization of fractionated radiotherapy. Strahlenther Onkol 168(6): 354-360.
16. Enderling, H., M.A.J. Chaplain, A.R.A Anderson, and J.S. Vaidya. 2007. A mathematical model of breast cancer development, local treatment and recurrence. J Theor Biol 246: 245-259.
17. FDA, Center for Drug Evaluation and Research. 1999. Application Number: 21029, Drug Name: Temozolomide (Temodal), New Drug Application, Clinical Pharmacology and Biopharmaceutics Reviews (Revision date: 2/2/1999), pp. 19-20.
18. Frieboes, H.B., X. Zheng, C.H. Sun, B. Tromberg, R. Gatenby, and V. Cristini. 2006. An integrated computational/experimental model of tumor invasion. Cancer Res 66(3): 1597-604.
19. Georgiadi, E. et al. 2008. Multilevel cancer modeling in the clinical environment: simulating the behavior of Wilms tumor in the context of the SIOP 2001/GPOH clinical trial and the ACGT project. Proc. 8th IEEE International Conference on Bioinformatics and Bioengineering (BIBE 2008), Athens, Greece, October 8-10, 2008. IEEE Catalog Number: CFP08266, ISBN: 978-1-4244-2845-8, Library of Congress: 2008907441, Paper No. BE-2.1.2.
20. Ginsberg, T., W. Ulmer, and W. Duechting. 1993. Computer simulation of fractionated radiotherapy: further results and their relevance to percutaneous irradiation and brachytherapy. Strahlenther Onkol 169: 304-310.
21. Graf, N. and Hoppe, A. 2006. What are the expectations of a clinician from in silico oncology? Proc. 2nd International Advanced Research Workshop on In Silico Oncology, Kolympari, Chania, Greece, September 25-26, 2006. Edited by K. Marias and G. Stamatakos. pp. 36-38. [www.ics.forth.gr/bmi/2nd-iarwiso/pdf/conf_proceedings_final.pdf].
22. Graf, N., C. Desmedt, A. Hoppe, M. Tsiknakis, D. Dionysiou, and G. Stamatakos. 2007. Clinical requirements of “in silico oncology” as part of the integrated project ACGT (Advancing Clinico-Genomic Trials on Cancer). Eur J Cancer Suppl. 5(4): 83.
23. Graf, N., C. Desmedt, F. Buffa, D. Kafetzopoulos, N. Forgo, R. Kollek, A. Hoppe, G. Stamatakos, and M. Tsiknakis. 2008. Post-genomic clinical trials—the perspective of ACGT. Ecancermedicalscience 2.
24. Graf, N., A. Hoppe, E. Georgiadi, R. Belleman, C. Desmedt, D. Dionysiou, M. Erdt, J. Jacques, E. Kolokotroni, A. Lunzer, M. Tsiknakis, and G. Stamatakos. 2009. “In silico oncology” for clinical decision making in the context of nephroblastoma. Klin Paediatr 221: 141-149.
25. Guiot, C, P.P. Delsanto, A. Carpinteri, N. Pugno, Y. Mansury, and T.S. Deisboeck. 2006. The dynamic evolution of the power exponent in a universal growth model of tumors. J Theor Biol 240(3): 459-463.
26. Haas-Kogan, D.A., G. Yount, M. Haas, D. Levi, S.S. Kogan, L. Hu et al. 1995. p53-dependent G1 arrest and p53 independent apoptosis influence the radiobiologic response of glioblastoma. Int J Radiat Oncol Biol Phys 36: 95-103.
27. Kansal, A.R, S. Torquato, G.R. Harsh, E.A. Chiocca, and T.S. Deisboeck. 2000. Simulated brain tumour growth dynamics using a three-dimensional cellular automaton. J Theor Biol 203: 367-382.
28. Katzung, B.G. Ed. 2001. Basic and Clinical Pharmacology, 8th ed. Lange Medical Books, McGraw-Hill, New York.
29. Kolokotroni, E.A., G.S. Stamatakos, D.D. Dionysiou, E.Ch. Georgiadi, Ch. Desmedt, and N.M. Graf. 2008. Translating multiscale cancer models into clinical trials: simulating breast cancer tumor dynamics within the framework of the “Trial of Principle” clinical trial and the ACGT project, Proc. 8th IEEE International Conference on Bioinformatics and Bioengineering (BIBE 2008), Athens, Greece, October 8-10, 2008. IEEE Catalog Number: CFP08266, ISBN: 978-1-4244-2845-8, Library of Congress: 2008907441, Paper No. BE-2.1.1.
30. Mansury, Y. and T.S. Deisboeck. 2003. The impact of “search precision” in an agent-based tumor model. J Theor Biol 224(3): 325-337.
31. Marias, K., D. Dionysiou, G.S. Stamatakos, F. Zacharopoulou, E. Georgiadi, T.G. Maris, and I. Tollis. 2007. Multi-level analysis and information extraction considerations for validating 4D models of human function. Lect Notes Comput Sci 4561: 703-709.
32. Morse, P.M. and H. Feshbach. 1953. Methods of Theoretical Physics. Part I, McGraw-Hill, New York. pp. 76-92.
33. Murray, J.D. 2003. Mathematical Biology II. Spatial Models and Biomedical Applications, 3rd ed. Springer-Verlag, Heidelberg, pp. 543-546.
34. Newlands, E.S., G.R. P. Blackledge, J.A. Slack et al. 1992. Phase I trial of temozolomide (CCRG 81045: M&B 39831:NSC 362856), Br. J. Cancer 65: 287-291.
35. Perez, C. and L. Brady, Eds., 1998. Principles and Practice of Radiation Oncology, 3rd ed. Lippincott-Raven, Philadelphia.
36. Perry, M.C. Ed. 2001. The Chemotherapy Source Book, 3rd ed. Lippincott Williams and Wilkins, Philadelphia.
37. Ramis-Conde, I., M.A.J. Chaplain, and A.R.A. Anderson. 2008. Mathematical modelling of cancer cell invasion of tissue. Math Comput Model 47: 533-545.
38. Salmon, S.E. and A.C. Sartorelli. 2001. Cancer chemotherapy. In Basic and Clinical Pharmacology. B.G. Katzung, Ed. Lange Medical Books/McGraw-Hill, International edition, pp. 923-1044.
39. Schiff, L.I. 1981. Quantum Mechanics, 3rd ed. McGraw Hill Kogakusha, Tokyo. pp. 148-186.
40. Stamatakos, G., E. Zacharaki, M. Makropoulou, N. Mouravliansky, A. Marsh, K. Nikita, and N. Uzunoglu. 2001a. Modeling tumor growth and irradiation response in vitro—a combination of high-performance computing and web based technologies including VRML visualization. IEEE Trans Inform Technol Biomed 5(4): 279-289.
41. Stamatakos, G.S, E.I. Zacharaki, N.K. Uzunoglu, and K.S. Nikita. 2001b. Tumor growth and response to irradiation in vitro: a technologically advanced simulation model. Int J Radiat Oncol Biol Phys 51(3) Suppl. 1: 240-241.
42. Stamatakos, G.S., D. Dionysiou, K. Nikita, N. Zamboglou, D. Baltas, G. Pissakas and N. Uzunoglu. 2001c. In vivo tumour growth and response to radiation therapy: a novel algorithmic description. Int J Radiat Oncol Biol Phys 51(3) Suppl. 1: 240.
43. Stamatakos, G.S., D.D. Dionysiou, E.I. Zacharaki, N.A. Mouravliansky, K.S. Nikita, and N.K. Uzunoglu 2002. In silico radiation oncology: combining novel simulation algorithms with current visualization techniques. Proc. IEEE. Special Issue on Bioinformatics: Adv. Challenges 90(11): 1764-1777.
44. Stamatakos, G. 2006. Spotlight on cancer informatics. Cancer Informatics 2: 83-86.
45. Stamatakos, G.S. and Uzunoglu, N. 2006. Computer simulation of tumour response to therapy. In S. Nagl, Ed. Cancer Bioinformatics: From Therapy Design to Treatment. John Wiley & Sons, Chichester, U.K. pp. 109-125.
46. Stamatakos, G.S., V.P. Antipas, N.K. Uzunoglu, and R.G. Dale. 2006a. A four dimensional computer simulation model of the in vivo response to radiotherapy of glioblastoma multiforme: studies on the effect of clonogenic cell density. Br J Radiol 79: 389-400.
47. Stamatakos, G.S., V.P. Antipas, and N.K. Uzunoglu. 2006b. A spatiotemporal, patient individualized simulation model of solid tumor response to chemotherapy in vivo: the paradigm of glioblastoma multiforme treated by temozolomide. IEEE Trans Biomed Eng 53: 1467-1477.
48. Stamatakos, G.S., V.P. Antipas, N.K. Uzunoglu. 2006c. Simulating chemotherapeutic schemes in the individualized treatment context: the paradigm of glioblastoma multiforme treated by temozolomide in vivo. Comput Biol Med. 36(11): 1216-1234.
49. Stamatakos, G.S., D.D. Dionysiou, N.M. Graf, N.A. Sofra, C. Desmedt, A. Hoppe, N. Uzunoglu and M. Tsiknakis. 2007a. The Oncosimulator: a multilevel, clinically oriented simulation system of tumor growth and organism response to therapeutic schemes. Towards the clinical evaluation of in silico oncology. Proc. 29th Annual Intern Conf IEEE EMBS. Cite Internationale, Lyon, France, August 23-26. SuB07.1: 6628-6631.
50. Stamatakos, G.S., D.D. Dionysiou, and N.K. Uzunoglu. 2007b. In silico radiation oncology: a platform for understanding cancer behavior and optimizing radiation therapy treatment. In M. Akay, Ed. Genomics and Proteomics Engineering in Medicine and Biology. Wiley-IEEE Press, Hoboken, NJ. pp. 131-156.
51. Stamatakos, G.S., 2008. In silico oncology: a paradigm for clinically oriented living matter engineering. Proc. 3rd International Advanced Research Workshop on In Silico Oncology, Istanbul, Turkey, September 23-24, 2008. Edited by G. Stamatakos and D. Dionysiou. pp. 7-9 [www.3rd-iarwiso.iccs.ntua.gr/procs.pdf].
52. Stamatakos, G.S., E. Kolokotroni, D. Dionysiou, E. Georgiadi, and S. Giatili. 2009. In silico oncology: a top-down multiscale simulator of cancer dynamics. Studying the effect of symmetric stem cell division on the cellular constitution of a tumour. In O. Dössel and W.C. Schlegel (Eds.): WC 2009, IFMBE Proceedings 25/IV, pp. 1830-1833, 2009.
53. Stamatakos, G. and D. Dionysiou. 2009. Introduction of hypermatrix and operator notation into a discrete mathematics simulation model of malignant tumour response to therapeutic schemes in vivo. Some operator properties. Cancer Informatics 2009:7 239-251.
54. Steel, G. Ed. Basic Clinical Radiobiology, 3rd ed., 2002. Oxford University Press, Oxford.
55. Stupp, R., M. Gander, S. Leyvraz, and E. Newlands. 2001. Current and future developments in the use of temozolomide for the treatment of brain tumours. Lancet Oncol Rev 2(9): 552-560.
56. Swanson, K.R., E.C. Alvord, and J.D. Murray. 2002. Virtual brain tumours (gliomas) enhance the reality of medical imaging and highlight inadequacies of current therapy. Br J Cancer 86: 14-18.
57. Werner-Wasik, M., C.B. Scott, D.F. Nelson, L.E. Gaspar, K.J. Murray, J.A. Fischbach, J.S. Nelson, A.S. Weinstein, and W.J. Jr. Curran. 1996. Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas. Radiation Oncology Therapy Group Study 83-02. Cancer 77(8): 1535-1543.
58. Zacharaki, E.I., G.S. Stamatakos, K.S. Nikita, and N.K. Uzunoglu. 2004. Simulating growth dynamics and radiation response of avascular tumour spheroid model validation in the case of an EMT6/Ro multicellular spheroid. Comput Methods Programs Biomed 76: 193-206.